Plasma viscosity: accuracy, precision and suitability – who wants it?
The diagnostic and prognostic value of plasma viscosity has been highlighted in patients suspected or confirmed as having COVID-19, but its use in other areas of UK medical practice has gained clinical acceptance over the past seven decades.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
Verulam Scientific Ltd is an analytical instrument company providing innovative solutions and emerging technologies to the UK pharmaceutical, environmental, life science, food, clinical and biotechnology markets. We provide laboratories with the equipment and services that are crucial to modern analytical services and research.